Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined...
Patent
1989-10-31
1995-05-16
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
424 9371, 4352401, 4352402, 43524021, 435 721, 435 724, 435723, 435 29, 435 34, A61K 3900, A61K 3514, C12N 500, C07K 300
Patent
active
054158745
ABSTRACT:
Lymphocytes of NK phenotype were cultured with stimulator cell lines in the presence of growth factor containing medium. The resulting lines and clones derived from these lines expressed CD16 and/or Leu 19, but lacked detectable CD3 or T cell receptor .gamma./.delta. complexes on the cell surface. In addition to displaying potent cytolytic activity against K562 erythroleukemia cells (a classical NK target), the vast majority of these lines and clones lysed their specific stimulator cell lines to a significantly greater extent than irrelevant cell lines. These results indicate that some CD3- lymphocytes, phenotypically indistinguishable from NK cells, can recognize and lyse allogeneic targets in a specific manner.
REFERENCES:
patent: 5028424 (1991-07-01), Evans
Bender et al. (1987) J. Clin. Invest. 79: 1679-1688.
Krensky, A. M., et al., Clin. Immunol. Rev. 4(1), 95-138 (1985).
Hercend, T., et al., Immunol. Today 9(10) 291-295 (1988).
Rosenberg, S., J. Natl. Cancer Inst. 75(4) 595-603 (1985).
Grimm, E. A., J. Exp. med. 155 1823-1841 (1982).
Pardi, R., et al., J. Immunol. 139(8) 2585-2592 (1987).
Bender, J. R., et al., J. Clin. Invest. 79 1679-1688 (1987).
Ciccone, E., et al., J. Exp. Med 168 2403-2408 (1988).
Ortaldo, J. R., et al., J. Immunol. 133(2) 779-783 (1884).
Bender Jeffrey R.
Engleman Edgar G.
Pardi Ruggero
Dehlinger Peter J.
Fabian Gary R.
Hill Jr. Robert J.
The Board of Trustees of the Leland Stanford Junior University
Wang Gian P.
LandOfFree
Natural killer cell lines and clones with antigen specificity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Natural killer cell lines and clones with antigen specificity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Natural killer cell lines and clones with antigen specificity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-636437